Navigation Links
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Date:5/21/2009

this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products, including GELNIQUE; the difficulty of predicting the timing or outcome of FDA approvals and actions, if any; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Annual Report on Form 10-K for the year ended December 31, 2008.


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine news :

1. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
2. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
3. Watson Files FDA Applications for Generic Mucinex(R)
4. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
5. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
6. Mark G. Watson Named Executive Director of Radiological Society of North America
7. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
8. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
9. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
10. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
11. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Blue Shield of Michigan announced today that Kevin Klobucar, ... current vice president for products and marketing, will succeed ... maintenance organization when Carlson retires at the end of ... Daniel J. Loepp, president and CEO of BCBSM, parent ... pending formal approval from the BCBSM and BCN boards ...
(Date:12/17/2009)... advice most effective when it comes from physician, study ... pediatrician,s advice has the most influence in convincing parents ... sleep in order to prevent sudden infant death syndrome, ... government launched the "Back to Sleep" campaign in 1994, ... sleep time has increased from 25 percent to 70 ...
(Date:12/17/2009)... stage at the Fisher Theatre on Dec. 17 for the Detroit-area,premiere ... survivors will be the real stars of the show. , ... ... takes the stage at the Fisher Theatre on Dec. 17 for ... cancer patients and cancer survivors will be the real stars ...
(Date:12/17/2009)... bowel disease (IBD) research were awarded the Crohn,s & ... 2009 Advances in Inflammatory Bowel Diseases Clinical & Research ... 4th. , ... ... clinical and scientific thought-leaders in inflammatory bowel disease (IBD) ...
(Date:12/17/2009)... Reportlinker.com announces that a new ... catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ,, ... animal health industry executives with strategically significant ... the development and implementation of effective marketing ... include: ,, To establish a ...
Breaking Medicine News(10 mins):Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 2Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 3Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 4Health News:Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases 5Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4
... consumption may be the culprit of hypertension in adolescents. ... healthy adolescents between 15 and 19 years old. ... milligrams daily of caffeine – the equivalent of about ... The number with the more serious impact was the ...
... intriguing results from a study involving women with leukemia who ... relative.An analysis of the women’s brains shows evidence of the ... transplant, suggesting some of the bone marrow cells were actually ... into any type of cell in the body, and once ...
... the diet may help reduce the risk of developing kidney ... than 95,000 women who never had kidney stones, researchers documented ... study. Women who consumed the most calcium had a 27-percent ... consumed the least amount. The use of calcium supplements was ...
... hereditary disease that affects thousands of Americans, appears to ... new study.// ,Researchers identified nearly 8,000 people over ... known risk factors such as socioeconomic class, urban residence, ... risk factors such as ulcerative colitis and Crohn’s disease ...
... in colder months. So if you’re worried about your cholesterol ... now rather than wait till the fall or winter. ... otherwise healthy men and women. All the participants had their ... total cholesterol was 222 milligrams/deciliter for the men in the ...
... that affects more than 21 million people in ... are pain, stiffness, reduced joint range of motion ... up from a chair, walking, balance and strength, ... medications such as acetaminophen, non-steroidal anti-inflammatory drugs and ...
Other Medicine News:
(Date:12/17/2009)... The Dr. Paul Janssen Award for ... nominations. The $100,000 Award recognizes individuals whose efforts ... of human health. Nomination forms are available ... until February 15, 2010. The Award winner is ... world,s top scientists, which features three new members ...
(Date:12/17/2009)... Fix the Bill ,, WASHINGTON, Dec. 17 ... for a Competitive Pharmaceutical Market (CCPM) will launch ... in select states charging that, during this holiday ... of all to brand pharmaceutical companies" by putting ... urge the President to tell Congress to fix ...
(Date:12/17/2009)... AMSTERDAM, December 17 ,Agendia, a world leader ... Food and Drug Administration (FDA) cleared its MammaPrint ... the only FDA-cleared,breast cancer recurrence test available to ... FDA has issued four clearances for MammaPrint, covering,all ... "This FDA clearance, along with our ...
Breaking Medicine Technology:Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 2Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 3FDA Broadens Clearance for Agendia's MammaPrint(R) 2Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 1Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 2Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 3A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 1Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 2Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 3
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: